Docetaxel, cisplatin and S-1 (DCS) combination chemotherapy for gastric cancer patients with peritoneal metastasis: a retrospective study.

Hiroyuki OhnumaYasushi SatoMasahiro HirakawaShohei KikuchiKoji MiyanishiTamotsu SagawaYasuo TakahashiTakayuki NobuokaKoichi OkamotoHiroshi MiyamotoIchiro TakemasaTetsuji TakayamaJunji Kato

Published in: Cancer chemotherapy and pharmacology (2018)

DCS is feasible and efficacious for AGC with PM, especially when patients present with a good PS.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
locally advanced
prognostic factors
peritoneal dialysis
particulate matter
air pollution
squamous cell carcinoma
radiation therapy
heavy metals
rectal cancer
polycyclic aromatic hydrocarbons